Investing
Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches
Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion ...
Investing
Applied Materials shares slide as China outlook darkens despite strong earnings
Applied Materials’ shares fell sharply in premarket trading on Friday, dropping more than 7%, after ...
Investing
Here’s why the S&P 500 Index and ETFs like VOO, SPY are falling
The S&P 500 Index and its ETFs like VOO and SPY has wavered in the ...
Investing
Emirates bets on SpaceX’s Starlink for global Wi-Fi lead: report
Emirates is preparing to transform its in-flight internet experience by partnering with SpaceX’s satellite service ...
Investing
US stocks open lower, extending selloff as tech stocks drag
US stocks fell sharply Friday as renewed selling in technology names weighed on broader markets, ...
Editor's Pick
Balancer Hack Update: Exploiter Begins Selling Stolen Tokens After Protocol Recovered $4.1M
The attacker behind the Balancer hack has begun to move and sell the stolen assets. ...
Editor's Pick
Ethereum Price Sheds 10% but Lands on the $3,150 Accumulation Base — Is a Buy-the-Dip Bounce Ahead?
Ethereum price begins the session under heavy pressure after today’s sharp crypto market crash erased ...
Editor's Pick
Visa’s Innovation Head Leaves TradFi Giant to Build On-chain Bank WeFi
WeFi:- From JPMorgan’s launch of its deposit token (JPM) to Visa piloting USDC settlements, the ...
Editor's Pick
Breaking: US SEC Issues Guidance on Pending Crypto ETFs as Government Shutdown Ends
The U.S. Securities and Exchange Commission (SEC) releases guidance related to crypto ETFs and other ...
Editor's Pick
XRP, DOGE & ADA Price Outlook: How Low Can These Altcoins Drop Next?
XRP, DOGE, and ADA have been heavily impacted by the continued decline in the cryptocurrency ...
